320 related articles for article (PubMed ID: 12906764)
1. EAE in the common marmoset Callithrix jacchus.
Uccelli A; Giunti D; Capello E; Roccatagliata L; Mancardi GL
Int MS J; 2003 Apr; 10(1):6-12. PubMed ID: 12906764
[TBL] [Abstract][Full Text] [Related]
2. Modelling of multiple sclerosis: lessons learned in a non-human primate.
't Hart BA; Laman JD; Bauer J; Blezer E; van Kooyk Y; Hintzen RQ
Lancet Neurol; 2004 Oct; 3(10):588-97. PubMed ID: 15380155
[TBL] [Abstract][Full Text] [Related]
3. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets.
Genain CP; Hauser SL
J Mol Med (Berl); 1997 Mar; 75(3):187-97. PubMed ID: 9106075
[TBL] [Abstract][Full Text] [Related]
4. Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.
Genain CP; Hauser SL
Immunol Rev; 2001 Oct; 183():159-72. PubMed ID: 11782255
[TBL] [Abstract][Full Text] [Related]
5. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
Massacesi L; Genain CP; Lee-Parritz D; Letvin NL; Canfield D; Hauser SL
Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
[TBL] [Abstract][Full Text] [Related]
6. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions.
Merkler D; Schmelting B; Czéh B; Fuchs E; Stadelmann C; Brück W
Mult Scler; 2006 Aug; 12(4):369-74. PubMed ID: 16900750
[TBL] [Abstract][Full Text] [Related]
7. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus).
't Hart BA; Massacesi L
J Neuropathol Exp Neurol; 2009 Apr; 68(4):341-55. PubMed ID: 19337065
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive measurement of brain damage in a primate model of multiple sclerosis.
't Hart BA; Vogels J; Bauer J; Brok HP; Blezer E
Trends Mol Med; 2004 Feb; 10(2):85-91. PubMed ID: 15102362
[TBL] [Abstract][Full Text] [Related]
9. Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development.
Kap YS; Laman JD; 't Hart BA
J Neuroimmune Pharmacol; 2010 Jun; 5(2):220-30. PubMed ID: 19826959
[TBL] [Abstract][Full Text] [Related]
10. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus).
Hart BA; Bauer J; Muller HJ; Melchers B; Nicolay K; Brok H; Bontrop RE; Lassmann H; Massacesi L
Am J Pathol; 1998 Aug; 153(2):649-63. PubMed ID: 9708823
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
12. Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide.
Peng Z; Zhang L; Wang H; He X; Peng X; Zhang Q; Liu H; Rao J; Wang H; Wu J; Sun Y
Protein Pept Lett; 2018 Feb; 24(12):1166-1178. PubMed ID: 29141529
[TBL] [Abstract][Full Text] [Related]
13. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain CP; Nguyen MH; Letvin NL; Pearl R; Davis RL; Adelman M; Lees MB; Linington C; Hauser SL
J Clin Invest; 1995 Dec; 96(6):2966-74. PubMed ID: 8675668
[TBL] [Abstract][Full Text] [Related]
14. A new primate model for multiple sclerosis in the common marmoset.
't Hart BA; van Meurs M; Brok HP; Massacesi L; Bauer J; Boon L; Bontrop RE; Laman JD
Immunol Today; 2000 Jun; 21(6):290-7. PubMed ID: 10825741
[TBL] [Abstract][Full Text] [Related]
15. The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis.
Kap YS; Jagessar SA; Dunham J; 't Hart BA
Drug Discov Today; 2016 Aug; 21(8):1200-5. PubMed ID: 27060373
[TBL] [Abstract][Full Text] [Related]
16. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
Kap YS; van Driel N; Arends R; Rouwendal G; Verolin M; Blezer E; Lycke N; 't Hart BA
Clin Exp Immunol; 2015 Apr; 180(1):28-39. PubMed ID: 25393803
[TBL] [Abstract][Full Text] [Related]
17. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.
Merkler D; Böscke R; Schmelting B; Czéh B; Fuchs E; Brück W; Stadelmann C
Brain Pathol; 2006 Apr; 16(2):117-23. PubMed ID: 16768751
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis.
Uccelli A; Giunti D; Mancardi G; Caroli F; Fiorone M; Seri M; Hauser SL; Genain CP
Eur J Immunol; 2001 Feb; 31(2):474-9. PubMed ID: 11180112
[TBL] [Abstract][Full Text] [Related]
19. Experimental Autoimmune Encephalomyelitis in Marmosets.
Jagessar SA; Dijkman K; Dunham J; 't Hart BA; Kap YS
Methods Mol Biol; 2016; 1304():171-86. PubMed ID: 25208751
[TBL] [Abstract][Full Text] [Related]
20. B-cell depletion abrogates T cell-mediated demyelination in an antibody-nondependent common marmoset experimental autoimmune encephalomyelitis model.
Jagessar SA; Heijmans N; Bauer J; Blezer EL; Laman JD; Hellings N; 't Hart BA
J Neuropathol Exp Neurol; 2012 Aug; 71(8):716-28. PubMed ID: 22805775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
